Rockwell Medical IncRMTI
Price$8.57Intrinsic value$7.5712% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $69.3M-31.8% YoYTTM through 31 Dec 2025
Net Income -$5.3MTTM through 31 Dec 2025
Free Cash Flow -$1.3MTTM through 31 Dec 2025

Margins

Current
Gross Margin16.9%
Operating Margin-6.8%
Net Margin-7.7%

Returns

-14.4%ROE
-9.3%ROA

Balance Sheet Health

Debt / Equity0.24x
Current Ratio3.98x
Net Debt-$16.2Mnet cash position
Cash & Equivalents$25M

Quality Metrics

FCF Margin-1.9%
Rule of 402.8
Earnings-Beat Rate0.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Hemodialysis Concentrates$69.3M-31.8%
View details

Management expects 2026 net sales to be between $70 million and $75 million, driven by pricing actions, new customer acquisitions, and operational changes.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.